Glaucoma 360 Symposia: The eye on education

The Glaucoma Symposium offers ophthalmology and optometry professionals an opportunity to sharpen their knowledge about glaucoma.

Techniques improve monovision for patients with presbyopia

Refractive surgeons are likely to enjoy success with monovision for presbyopia if they aim for a maximum of 1.50 D of residual myopia in the non-dominant eye, exclude patients with pre-existing strabismus, and monitor for signs of strabismus.

CXL demands continuity of care

Crosslinking meets the previously unmet needs of progressive keratoconus patients and provides an opportunity to increase engagement with optometrists, explain John Berdahl, MD, and George O. Waring IV, MD.

Verteporfin does not improve efficacy of ranibizumab for AMD (VIDEO)

September 05, 2014

William Fredette, MD, discusse the results of two trials published in Opthalmology, which indicate that the combination of Verteporfin Photodynamic Therapy plus ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularization secondary to AMD. Video provided by The Doctor's Channel.

DES market expected to grow about $4 billion in 10 years

July 25, 2013

As dry eye syndrome (DES) affects more and more patients over the next 10 years, pharmaceutical companies are expecting to expand their clinical products globally to treat the condition, thus tripling the market’s global revenue over the next decade.

Cause of cone death discovered in retinitis pigmentosa

September 06, 2012

Researchers have identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigments (RP).

Welch Allyn facility earns LEED environmental certification

September 06, 2012

The Welch Allyn facility in Beaverton, OR, earned Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.

Glaucoma may be linked to depression

September 06, 2012

Glaucoma may be a significant predictor of depression, according to research published in the American Journal of Ophthalmology.

Trifocal diffractive intraocular lens reduces spectacle dependency

September 06, 2012

A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after cataract surgery and provides patient satisfaction.

Phase II study for travoprost punctum plugs

August 29, 2012

Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.